| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |